( July 22, 2026, 1:44 PM EDT) -- NEWARK, N.J. — An attorney representing the manufacturer of Ozempic, Wegovy and Rybelsus told a federal magistrate judge in New Jersey that the drugmaker and an aesthetic medical practice facing allegations that it improperly marketed and sold compounded drug products that purport to contain semaglutide XE "semaglutide" are continuing their efforts to settle the case....